Bence Jones Cast Nephropathy

Mar 11, 2017 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Bence Jones Cast Nephropathy

, Arthur H. Cohen2, Robert B. Colvin3, J. Charles Jennette4 and Charles E. Alpers5 (1) Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA (2) Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center,…

read more

Membranous Nephropathy

Mar 11, 2017 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Membranous Nephropathy

, Arthur H. Cohen2, Robert B. Colvin3, J. Charles Jennette4 and Charles E. Alpers5 (1) Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA (2) Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center,…

read more

Postinfectious Glomerulonephritis

Mar 11, 2017 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Postinfectious Glomerulonephritis

, Arthur H. Cohen2, Robert B. Colvin3, J. Charles Jennette4 and Charles E. Alpers5 (1) Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA (2) Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center,…

read more

Thin Basement Membranes and Alport Syndrome

Mar 11, 2017 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Thin Basement Membranes and Alport Syndrome

, Arthur H. Cohen2, Robert B. Colvin3, J. Charles Jennette4 and Charles E. Alpers5 (1) Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA (2) Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center,…

read more

The “Pharmacotherapy Needs a Premium” Game

Mar 10, 2017 by in PHARMACY Comments Off on The “Pharmacotherapy Needs a Premium” Game

(1) University of South Australia, Adelaide, Australia   Abstract This chapter presents “The pharmacotherapy needs a premium” Game where the Institution that lowers the decision threshold must respond to the…

read more

The “Pharmaceutical R&D Financing” Game

Mar 10, 2017 by in PHARMACY Comments Off on The “Pharmaceutical R&D Financing” Game

(1) University of South Australia, Adelaide, Australia   Abstract This chapter presents “The pharmaceutical R&D financing” game in which the Institution lowers the decision threshold and must respond to a…

read more

The “New Drug Reimbursement” Game

Mar 10, 2017 by in PHARMACY Comments Off on The “New Drug Reimbursement” Game

(1) University of South Australia, Adelaide, Australia   Abstract If a new drug’s incremental price-effectiveness ratio (IPER) is above the health shadow price, β c , the best alternative strategy…

read more

The Health Shadow Price and the Economic Context

Mar 10, 2017 by in PHARMACY Comments Off on The Health Shadow Price and the Economic Context

(1) University of South Australia, Adelaide, Australia   Abstract The value of clinical innovation of a new drug is specific to a particular clinical context; the patient group, the clinical…

read more
Get Clinical Tree app for offline access